NCT07444281 2026-03-03
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
Shanghai AbelZeta Ltd.
Phase 1 Recruiting
Shanghai AbelZeta Ltd.
Jiangsu Cancer Institute & Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Centre Hospitalier Universitaire de la Réunion
Queen Mary University of London
First People's Hospital of Hangzhou
Sanofi
Tianjin Medical University Cancer Institute and Hospital